Terazosin Hydrochloride Anhydrous
- Product NDC
- 43063-495
- 11-digit product format
- 430630495
- Labeler code
- 43063
- Product ID
- 43063-495_7c72331b-cae4-0ced-e053-2a91aa0a0856
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- terazosin hydrochloride anhydrous
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Application
- ANDA075140
- Marketing category
- ANDA
- Marketing start
- 2000-02-22
- Marketing end
- 0000-00-00
- Substance
- TERAZOSIN HYDROCHLORIDE ANHYDROUS
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record